Bioreactors Market: Exploring Opportunities and Emerging Trends
The global bioreactors market is expected to grow at a CAGR of 6.8%. The study on global bioreactors market includes volume market for stainless steel, single-use and glass bioreactors. Factors such as the increase in adoption of single-use technologies, use of hybrid technologies: single-use and stainless steel, growing popularity of single-use bioreactor among biopharmaceutical companies, and growing biologics market are fueling the growth of this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=59253123
This
report mainly considers three types of bioreactor material Glass,
stainless steel, and single-use bioreactors. Glass bioreactors are
majorly used for R&D and scaling up process development. They are
also used in academic and research institutes. The single-use segment
commanded around 41% of the global bioreactors market, in terms of
volume. The large percentage of this segment is attributed to the
widespread usage of single-use bioreactors across clinical and
commercial production.
In this report, the bioreactors market is
segmented into four major geographic segments, namely, North America,
Europe, Asia-Pacific, and Rest of the World. In terms of volume, North
America accounted for 42% of the total bioreactors market, by region.
Asia-Pacific countries are expected to show the highest growth, being
emerging markets for bioreactors owing to the expansion of the
biopharmaceutical sector in this region. China, for instance, is the
most preferred destination for leading biopharma companies for the
production of biologics, and has attracted significant investment in
this field.
This research study is aimed at identifying emerging
trends and opportunities in the global bioreactors market along with
detailed classifications, in terms of revenue. It provides comprehensive
competitive landscape and identifies the key players with respect to
percentage share. The research study also includes a detailed
segmentation of the global bioreactors market, on the basis of end-user,
usage, scale, material, control type, and suppliers.
The major
players operating in global bioreactor market include Sartorius AG
(Germany), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany),
GE Healthcare (A subsidiary of General Electric Company) (U.S.), Danaher
Corporation (U.S), Eppendorf AG (Germany), and major EPC players
included in this report are Amec Foster Wheeler plc (U.K.), Fluor
Corporation (U.S.), Jacobs Engineering Group Inc. (U.S.), M+W Group
(Germany), PM Group (Ireland), and Technip S.A. (France).
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=59253123
The global bioreactor market
is fragmented and competitive, with a significant number of global and
regional market players. This segment studies the growth strategies
adopted by key market players between 2013 and 2016. Leading players in
the bioreactor market have adopted various strategies to expand their
global presence and increase their market shares. New product launches,
FDA approval, and acquisitions are some of the key strategies adopted by
the market players to achieve growth in the bioreactor market.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment